Leveraging Resources to Generate Outputs and Lead the Global Biotech Innovation – Policy is Key!

Posted by:

Leveraging Resources to Generate Outputs and Lead the Global Biotech Innovation – Policy is Key!

Most, if not all countries today view biotechnology as a strategic area for economic and social development and growth. Most, if not all countries today wish to leverage existing resources such as academic and research facilities and human capital to create a globally-competitive knowledge-based economy. Some have succeeded where others failed. Why?

 

Earlier last week Professor Meir Pugatch moderated the Global Leadership Forum at the BIO International Convention that was held at Boston, MA. The panel, titled “Can Boston’s DNA be ...

Continue Reading →
0

Innovation

A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Proven

Posted by:

A New Era For Russian Biotechnology In 2030 – Remains To Be Seen And Proven

Professor Meir Pugatch spoke at the St. Petersburg International Economic Forum (SPIEF) in the panel: “Life Sciences in 2030: A New Era for Biotechnology” which took place on May 26, 2018 and included the Deputy Ministers of the Ministries of Health, Industry and Trade, and Agriculture of the Russian Federation, as well as Senior Executives of top MNCs in the private sector. Prof. Pugatch presented key highlights of Pugatch Consilium’s research concerning the enabling conditions for developing a competitive bioeconomy ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis

Daniel Coriat Sharing the Results of the BCI 2017 | Hosted by the CIF

Posted by:

Daniel Coriat Sharing the Results of the BCI 2017 | Hosted by the CIF

In Santiago de Chile, Daniel Coriat shared the results of the BCI 2017 with a distinguished audience at an event hosted by CIF, the local Chilean pharmaceutical trade association.  During the event, representatives of the Ministry of Economy and the Ministry of Foreign Affairs highlighted the importance that the BCI tool provides as empirical evidence of the effects of public policy.  Here Dan is being interviewed by a renowned journalist in Chile about the BCI:

http://www.infinita.cl/entrevistas/2018/05/09/daniel-coriat-director-consultora-pugatch-consilium

Continue Reading →
0

Innovation, Market Analysis, Pharmaceuticals & Healthcare

Is Taiwan Ready for the Top Spot?

Posted by:

Is Taiwan Ready for the Top Spot?

Professor Meir Pugatch spoke today at the forum “Positioning Taiwan as an Asia-Pacific Biomedical R&D Hub” which took place the International Convention Center in Taipei, and included the Vice President of Taiwan and additional government officials.

Professor Pugatch presented a comprehensive analysis of Taiwan’s competitiveness in the biotech sector, as well as recent improvements to and remaining challenges in Taiwan’s path to leadership in global biotech innovation.

By utilizing a competitive mentality that views policy as instrumental in achieving economic and societal ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare, Technology Transfer

Daniel Coriat on Colombia’s standing in the BCI report

Posted by:

Daniel Coriat on Colombia’s standing in the BCI report

As part of the coverage of the event celebrating 60 years of Afidro where industry, government, patient groups and other stakeholders gathered in Bogota on March 2018, a leading 24-hour news channels in Colombia interviews Pugatch Consilium’s Daniel Coriat on Colombia’s standing in the BCI report. Daniel explains how policies not geared to promote innovation hurt Colombia’s international standing and competitiveness in attracting foreign direct investment.

Listen to the interview

Continue Reading →
0

Innovation, Market Analysis

Towards a Sustainable European Market for Off-Patent Biologics

Posted by:

Towards a Sustainable European Market for Off-Patent Biologics

Professor Meir Pugatch spoke yesterday at the event: “Building a sustainable Policy Framework for Biologics and Biosimilar Medicines in Europe”, which took place at the European Parliament, and included members from the European Commission and organizations such as Medicines for Europe, ESMO and EPF. Professor Pugatch presented the findings of a new study by Pugatch Consilium, commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA).

With 38 biosimilar medicines approved and marketed and hundreds of clinical trials on ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare

Why IP Incentives Matter for Life Sciences Innovation – In Europe and Beyond

Posted by:

Why IP Incentives Matter for Life Sciences Innovation – In Europe and Beyond

Why IP incentives matter for life sciences innovation – In Europe and Beyond

Pugatch Consilium is today releasing a new report – A Critical Incentive – Not a Barrier! How IP incentives spur biopharmaceutical innovation and the creation of new health technologies.

This report examines the importance of IP based incentives to biopharmaceutical innovation and the development of new medicines and medical technologies.

This analysis could not be more timely. In Europe, for example, the EU Commission is seriously considering ways to ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis

BCI 2017 Latin America Report and Results Released

Posted by:

BCI 2017 Latin America Report and Results Released

Pugatch Consilium unveiled at the Financial Times Latin America Healthcare & Life Sciences Summit in Sao Paulo Brazil the 2017 Biopharmaceutical Competitiveness & Investment (BCI) Latin America Special Report. This Report is derived from the main 2017 BCI Survey, a global executive opinion survey and index that measures the relative attractiveness of economies to investment from biopharmaceutical research-based companies.

The Report deep-dives into ten Latin American countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Mexico, Panama and Peru. ...

Continue Reading →
0

Innovation, Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare

Debunking the IP and Access to Medicines Myth Once and For All

Posted by:

Debunking the IP and Access to Medicines Myth Once and For All

Pugatch Consilium is today releasing the report Unlocking Global Health Strengthening Availability of Essential Medicines by Enhancing Healthcare Financing and Reducing Supply Chain Costs.

This report examines a common misperception in the international community: that patents and IP incentives block access to medicines.

 

An age-old debate: Patents and access

Discussions over the impact – positive or negative; rarely neutral – that IP rights have had and continue to have on the creation and dissemination of new ideas and commercial products is ...

Continue Reading →
0

Intellectual Property, Market Analysis, Pharmaceuticals & Healthcare

Page 2 of 15 12345...»